
David Loew
Vermögen: 12 Mio $ am 31.01.2026

Vermögen: 12 Mio $ am 31.01.2026
David G. Loew ist Chief Executive Officer & Director bei Ipsen SA und Chief Executive Officer bei Ipsen Pharma SAS (einer Tochtergesellschaft von Ipsen SA). In der Vergangenheit war er Executive Vice President-Sanofi Pasteur bei Sanofi und Global Head-Product Strategy bei Genentech, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IPSEN SA 0,09 % | 31.12.2024 | 74.932 ( 0,09 % ) | 12 Mio $ | 31.01.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IPSEN | Vorstandsvorsitzender | 01.07.2020 |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | 30.07.2020 |
G5 Santé | Direktor/Vorstandsmitglied | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Operates as biopharmaceutical company | Vorstandsvorsitzender | 01.07.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 15.06.2020 |
GAVI Alliance
GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Genentech, Inc.
Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | |
Roche Holding AG
Roche Holding AG Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GAVI Alliance
GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Operates as biopharmaceutical company | |
G5 Santé |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition